NinePointTwo Capital »

Fate Therapeutics shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-03-31 $281k 49k 5.70
2022-12-31 $127k 13k 10.08

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management
Two Sigma Advisers

View all funds holding Fate Therapeutics